Cappuccini, F., Bryant, R., Pollock, E., Carter, L., Verrill, C., Hollidge, J., Poulton, I., Baker, M., Mitton, C., Baines, A., Meier, A., Schmidt, G., Harrop, R., Protheroe, A., MacPherson, R., Kennish, S., Morgan, S., Vigano, S., Romero, P. J., Evans, T., Catto, J., Hamdy, F., Hill, A. V. S., & Redchenko, I. (2020). safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial. Journal for immunotherapy of cancer, 8(1), . http://access.bl.uk/ark:/81055/vdc_100127569997.0x00002e